AntibioticDB

Clofazimine

Riminophenazine

Novartis, Switzerland

1986

Highest development stage: Phase 2
Mechanism of Action/Target pathogen: Antimycobacterial properties (used against Mycobacterium avium and Mycobacterium leprae)
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9184
Source: https://www.jaad.org/article/0190-9622(95)90134-5/pdf
Citation (1): https://aac.asm.org/content/64/5/e02349-19
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/2794